Cartridge-Based Autoinjectors Market
完整報告名稱與涵蓋範圍
Cartridge-Based Autoinjectors Market Size, Share & Trends Analysis Report, By Device Type (Disposable Cartridge-Based Autoinjectors, Reusable Cartridge-Based Autoinjectors, Multi-Dose and Variable-Dose Cartridge Autoinjectors), By Cartridge Format (1.5 mL Cartridges, 3 mL Cartridges, Dual-Chamber and Specialty Cartridges), By Therapeutic Application (Diabetes and Obesity (GLP-1 and Insulin), Growth Hormone, Fertility and Endocrine Therapies, Immunology and Biologics, Emergency and Other Applications), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The cartridge-based autoinjectors market covers disposable, reusable and multi-dose autoinjectors built around glass or polymer cartridge primary containers rather than prefilled syringes, together with the cartridges and platform components supplied to pharmaceutical partners, across diabetes and obesity, endocrine, immunology and emergency applications. Prefilled-syringe autoinjectors, pen injectors with manual dose dialling and wearable injectors are excluded but analysed as competing formats; multi-dose pen injectors for cardiometabolic therapies are addressed in a separate InsightAce study.
Cartridge formats are gaining ground because they support larger fill volumes and multi-dose regimens, allow reusable electromechanical mechanisms that reduce waste and per-dose cost, and align with the high-volume filling lines used for incretin and insulin products. The incretin boom has created enormous demand for cartridge-based devices, prompting capacity expansion by platform companies and cartridge suppliers, while pharmaceutical companies pursue proprietary platforms to secure supply and differentiate. Device makers compete on dose accuracy, needle-shielding and safety features, connectivity, human factors and sustainability, and regulators require combination product verification that favours platforms with established approval histories.
Europe and North America host the leading platform companies and most demand, with China and India expanding cartridge device manufacturing for generic incretins and insulins. Competition involves Swiss and European device platform leaders, packaging and glass container groups, medical device contract manufacturers and pharmaceutical companies with in-house platforms.
The InsightAce study includes revenue forecasts in US$ for all device type, cartridge format, therapeutic application and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cartridge-Based Autoinjectors Market Snapshot
Chapter 4. Global Cartridge-Based Autoinjectors Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Device Type Estimates & Trend Analysis
5.1. Device Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Device Type:
5.2.1. Disposable Cartridge-Based Autoinjectors
5.2.2. Reusable Cartridge-Based Autoinjectors
5.2.3. Multi-Dose and Variable-Dose Cartridge Autoinjectors
Chapter 6. Market Segmentation 2: By Cartridge Format Estimates & Trend Analysis
6.1. Cartridge Format & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Cartridge Format:
6.2.1. 1.5 mL Cartridges
6.2.2. 3 mL Cartridges
6.2.3. Dual-Chamber and Specialty Cartridges
Chapter 7. Market Segmentation 3: By Therapeutic Application Estimates & Trend Analysis
7.1. Therapeutic Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Therapeutic Application:
7.2.1. Diabetes and Obesity (GLP-1 and Insulin)
7.2.2. Growth Hormone, Fertility and Endocrine Therapies
7.2.3. Immunology and Biologics
7.2.4. Emergency and Other Applications
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Home Users and Patients
8.2.3. Hospitals and Clinics
Chapter 9. Cartridge-Based Autoinjectors Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Ypsomed AG
11.2. SHL Medical AG
11.3. Becton, Dickinson and Company
11.4. Haselmeier (medmix AG)
11.5. Owen Mumford Ltd.
11.6. Nemera
11.7. Phillips-Medisize (Molex, Koch Industries)
11.8. Gerresheimer AG
11.9. Stevanato Group S.p.A.
11.10. Schott Pharma AG & Co. KGaA
11.11. West Pharmaceutical Services, Inc.
11.12. Jiangsu Delfu Medical Device Co., Ltd.
11.13. Novo Nordisk A/S (Device Platforms)
11.14. Eli Lilly and Company (Device Platforms)
11.15. Sanofi (Device Platforms)
圖表清單 List of Tables & Figures
Table 1. Global Cartridge-Based Autoinjectors Revenue Forecast by Device Type, 2026-2035 (US$ Mn)
Figure 1. Global Cartridge-Based Autoinjectors Market Snapshot, 2026 & 2035
Table 2. Global Cartridge-Based Autoinjectors Revenue Forecast by Cartridge Format, 2026-2035 (US$ Mn)
Figure 2. Global Cartridge-Based Autoinjectors Market Share by Cartridge Format, 2026 & 2035
Table 3. Global Cartridge-Based Autoinjectors Revenue Forecast by Therapeutic Application, 2026-2035 (US$ Mn)
Figure 3. Cartridge Versus Prefilled Syringe Autoinjector Positioning by Fill Volume and Dosing Regimen
Table 4. Global Cartridge-Based Autoinjectors Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Incretin Therapy Volumes and Cartridge Device Capacity Expansion, 2024-2030
Table 5. North America Cartridge-Based Autoinjectors Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Cartridge-Based Autoinjectors Growth Opportunity Analysis
Table 6. Europe Cartridge-Based Autoinjectors Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Reusable Electromechanical Cartridge Devices: Cost, Sustainability and Connectivity Advantages
Table 7. Asia Pacific Cartridge-Based Autoinjectors Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Cartridge-Based Autoinjectors Market Participants
Table 8. Latin America and Middle East & Africa Cartridge-Based Autoinjectors Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們